Blood-Test Customers Mistakenly Told They May Have Cancer

France Nouvelles Nouvelles

Blood-Test Customers Mistakenly Told They May Have Cancer
France Dernières Nouvelles,France Actualités
  • 📰 WSJ
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 63%

About 400 people who signed up for a cancer-detection blood test from Grail were incorrectly told they may have the disease, according to the company, which blamed the mistakes on a partner’s software glitch

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

Grail said its telemedicine vendor sent inaccurate forms because of a software glitchGrail, a developer of multi-cancer early-detection blood tests, says about 400 customers were notified mistakenly that they may have the disease.Cancer blood-test maker Grail said about 400 customers were mistakenly notified that its test detected a cancer signal in them, which the company attributed to a partner’s software glitch.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

WSJ /  🏆 98. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Grail says about 400 patients incorrectly informed they may have cancerGrail says about 400 patients incorrectly informed they may have cancerCancer test maker Grail Inc said on Friday that its telemedicine vendor erroneously sent letters to about 400 patients suggesting they may have developed cancer.
Lire la suite »

Software snafu leads to 400 Grail patients getting bogus letters saying they might have cancerSoftware snafu leads to 400 Grail patients getting bogus letters saying they might have cancerGrail, owned by San Diego's Illumina, said erroneous letters were triggered by a software problem at a third-party telemedicine vendor. Patients have been contacted alerting them that the notification was inaccurate
Lire la suite »

Deadpool: Badder Blood #1 Preview: A Prequel to Baddest BloodDeadpool: Badder Blood #1 Preview: A Prequel to Baddest BloodCheck out our preview of the upcoming Deadpool: Badder Blood 1, hitting stores June 7th! Will Deadpool, Wolverine, and Cable be badder than ever? Find out in our latest article! Deadpool MarvelComics ComicPreview
Lire la suite »

Local blood supply reaches critical levels, South Texas Blood and Tissue Center saysLocal blood supply reaches critical levels, South Texas Blood and Tissue Center saysThe South Texas Blood and Tissue Center said it has reached a critical supply level for all blood types. Roger Ruiz, with the STBTC, said the recent drop in donations is due to the summer break. High school and college blood drives are major contributors to the blood supply. If you would like to help, there are opportunities over the weekend.
Lire la suite »

Multi-cancer blood test shows real promise in NHS studyMulti-cancer blood test shows real promise in NHS studyThe Galleri test revealed the correct site of a tumour 85% of the time in a study with 5,000 patients.
Lire la suite »

Spotting the Seeds of Neurodegeneration – Scientists Develop a Groundbreaking Blood Test for SynucleinopathiesSpotting the Seeds of Neurodegeneration – Scientists Develop a Groundbreaking Blood Test for SynucleinopathiesResearchers have engineered a novel assay that can identify specific neurodegenerative disorders by detecting irregular α-synuclein present in patient sera. Researchers from Japan have pioneered a new test that can identify seeds, or clusters, of abnormally folded α-synuclein proteins in the bloo
Lire la suite »



Render Time: 2025-03-06 14:43:32